VASCULAR INJURY CORRECTION IN ARTERIAL HYPERTENSION: FOCUS ON PERINDOPRIL
Abstract
Risk factors are the cornerstone of the cardiovascular continuum concept. Arterial hypertension is one of major risk factors, which accounts for a substantial proportion of cardiovascular morbidity and mortality due to cardiovascular complications (CVC). The latter develop due to, among other reasons, the damage of the vascular component of cardiovascular system (CVS). Presently, the aims of antihypertensive treatment include not only control of blood pressure levels, but also CVC prevention. Antihypertensive medications of choice include the agents which also possess vasoprotective qualities.
About the Authors
Yu. N. Belenkov
Hospital Therapy Department No. 1, Therapy Faculty, I.M. Sechenov First Moscow State Medical University, Moscow
Russian Federation
Russian Federation
E. V. Privalova
Hospital Therapy Department No. 1, Therapy Faculty, I.M. Sechenov First Moscow State Medical University, Moscow
Russian Federation
Russian Federation
Yu. A. Danilogorskaya
Department of Chronomedicine and New Technologies in Internal Medicine, Research Centre, I.M. Sechenov First Moscow State Medical University, Moscow
Russian Federation
Russian Federation
E. A. Zheleznykh
Department of Chronomedicine and New Technologies in Internal Medicine, Research Centre, I.M. Sechenov First Moscow State Medical University, Moscow
Russian Federation
Russian Federation
A. A. Shchendrygina
Hospital Therapy Department No. 1, Therapy Faculty, I.M. Sechenov First Moscow State Medical University, Moscow
Russian Federation
Russian Federation
References
1. Shalnova S.A., Balanova J.A., Konstantinov B. D. et al. Hypertension: prevalence, awareness, reception of anti-hypertensive preparations and efficiency of treatment among the population of the Russian Federation RCJ 20064: 45–50. Russian (Шальнова С.А., Баланова Ю.А., Константинов В.В. и др. Артериальная гипертония: распространенность, осведомленность, прием антигипертензивных препаратов и эффективность лечения среди населения Российской Федерации. Российский кардиологический журнал 2006; 4: 45–50).
2. Antonios T.F.T. et al. Rarefaction of Skin Capillaries in Borderline Essential Hypertension Suggests an Early Structural Abnormality. Hypertension 1999; 34:655–658
3. Ezzati M., Lopez A. D., et al. Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360 (9343):1347–60.
4. Hypertension: management of hypertension in adults in primary care. NICE clinical guideline 34. www.nice.org.uk/CG034NICEguideline.
5. Ceconi C, Fox K, Remme WJ et al. ACE inhibition with perindopril and endothelial dysfunction. Results of a substudy of the EUROPA study: PERTINENT. Cardiovasc Res 2007; 73: 237–46.
Review
For citations:
Belenkov Yu.N., Privalova E.V., Danilogorskaya Yu.A., Zheleznykh E.A., Shchendrygina A.A. VASCULAR INJURY CORRECTION IN ARTERIAL HYPERTENSION: FOCUS ON PERINDOPRIL. Russian Journal of Cardiology. 2012;(3):85-87. (In Russ.)
Views:
420
Email this article 